DOI: 10.1055/s-00000036

Laryngo-Rhino-Otologie

References

Humbert M, Beasley R, Ayres J. et al.
Benefits of omalizumab as add-on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATE. 
Allergy 2005; 60: 309-316  

Download Bibliographical Data

Search in:
Access: